Tripuraneni Radhika bought VRDN
August 14, 2026 · Form 4 insider transaction
Tripuraneni Radhika bought 40,000 shares of Viridian Therapeutics, Inc. at $13.21 per share, a transaction worth $528.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$13.21
Total value
$528.4K
InsiderTripuraneni Radhika
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 14, 2026
Filing dateAugust 18, 2026
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo